Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2026-04-16 @ 7:44 AM
Study NCT ID:
NCT01224795
Status:
TERMINATED
Last Update Posted:
2015-01-06
First Post:
2010-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
Sponsor:
BioCryst Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BCX1812-304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |